Andilab, Meryll Faith .

HRN: 28-63-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
CEFTRIAXONE 1G (VIAL)
02/26/2026
03/04/2026
IV
2gms
OD
T/C CAP-MR
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines